Sale of GSK
GSK (Ex-US strategy) sold due to poor future dividend growth prospects.
GSK
Purchase of GlaxoSmithKline plc (NYSE:GSK)
As part of my “Ex-US International ETFs and Dividend Stocks” strategy, I bought GlaxoSmithKline plc (NYSE:GSK).
Purchase of GlaxoSmithKline plc (NYSE:GSK) Read More »
7 new titles followed
Discover the nine new stocks I now follow as part of my investment strategies, including giants like GlaxoSmithKline and HSBC. With a total of 133 dividend growth stocks, tap into the potential of stocks traded on the London Stock Exchange, where dividends are exempt from withholding tax.
7 new titles followed Read More »
Dividends from Great Britain: three cash cows
In an in-depth analysis of three promising UK companies - British American Tobacco (BTI), GlaxoSmithKline (GSK) and Unilever (UL) - the article examines their growing dividend potential and the tax advantage of no withholding tax. The study details the investment prospects of these companies, highlighting their reasonable debt levels while recommending waiting for a significant market downturn before investing.
Dividends from Great Britain: three cash cows Read More »
Français 
English 
Italiano 
Deutsch 
Español 
Português